Ribociclib plus letrozole in male patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: subgroup analysis of the phase IIIb CompLEEment-1 trial-论文-万方医学网

首页> > Ribociclib plus letrozole in male patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: subgroup analysis of the phase IIIb CompLEEment-1 trial

Ribociclib plus letrozole in male patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: subgroup analysis of the phase IIIb CompLEEment-1 trial

导出原文传递

翻译打印收藏纠错

第一作者： Campone, Mario

作者： Campone, Mario ^[1] ; De Laurentiis, Michelino ^[2] ; Zamagni, Claudio ^[3] ; Kudryavcev, Igor ^[4] ; Agterof, Mariette ^[5] ; Brown-Glaberman, Ursa ^[6] ; Palacova, Marketa ^[7] ; Chatterjee, Sanjoy ^[8] ; Menon-Singh, Lakshmi ^[9] ; Wu, Jiwen ^[10] ; Martin, Miguel

作者单位： Western Canc Inst ^[1] Ist Nazl Tumori IRCCS Fdn Pascale ^[2] IRCCS Azienda Osped Univ Bologna ^[3] Kaluga Reg Clin Oncol Ctr ^[4] St Antonius Hosp ^[5] Ctr Canc,Univ New Mexico ^[6] Masaryk Mem Canc Inst ^[7] Tata Med Ctr ^[8] Novartis Pharmaceut ^[9] Gregorio Maranon Gen Univ Hosp ^[10]

关键词 Advanced breast cancer Ribociclib Men Real-world evidence Male breast cancer STATISTICS SURVIVAL MANAGEMENT THERAPY MEN

发布时间 2022-06-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Ribociclib plus letrozole in male patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: subgroup analysis of the phase IIIb CompLEEment-1 trial

相似文献

同项目论文

相关期刊

检索历史 清除

Ribociclib plus letrozole in male patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: subgroup analysis of the phase IIIb CompLEEment-1 trial

相似文献

同项目论文

相关期刊

检索历史清除